5 Cheap Pharmaceutical Stocks For 2022

Page 1 of 5

In this article, we discuss 5 cheap pharmaceutical stocks for 2022. If you want to read our detailed analysis of these stocks, go directly to 10 Cheap Pharmaceutical Stocks For 2022

5. Evolus, Inc. (NASDAQ:EOLS)

Number of Hedge Fund Holders: 12   

Real-Time Share Price as of February 15: $8.85 

Evolus, Inc. (NASDAQ:EOLS) operates as a medical aesthetics firm. On January 20, Truist analyst Gregory Fraser upgraded the stock to Buy from Hold with a price target of $11, noting that the strong fundamentals of the firm indicated it was well-positioned for the launch of new drugs and the chance to evolve the business model to suit other products. 

Elite hedge funds hold large stakes in Evolus, Inc. (NASDAQ:EOLS). At the end of the third quarter of 2021, 12 hedge funds in the database of Insider Monkey held stakes worth $28 million in Evolus, Inc. (NASDAQ:EOLS), the same as in the previous quarter worth $42 million.

Page 1 of 5